NCT02576847: A trial that was reported late by Maruho Co., Ltd.
This trial has reported, although it was 699 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02576847 |
|---|---|
| Title | A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 31, 2015 |
| Completion date | July 14, 2017 |
| Required reporting date | July 14, 2020, midnight |
| Actual reporting date | June 13, 2022 |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | 699 |